Cerenome, Inc. (CNSY) vs GT Biopharma, Inc. (GTBP)
- Cerenome, Inc. CNSY 1.70 −9.57%
- GT Biopharma, Inc. GTBP 7.03 −4.48%
Cerenome, Inc. and GT Biopharma, Inc. are both Biotechnology companies. Cerenome, Inc. and GT Biopharma, Inc. are of similar size ($15.2M and $14.3M). Cerenome, Inc. grew revenue faster over the last twelve months: −21.0% against −76.2%. GT Biopharma, Inc. has the higher net margin (0.00% vs −526.5%) and the higher return on invested capital (0.00% vs −532.8%). Across the 17 metrics below, GT Biopharma, Inc. leads on 10 and Cerenome, Inc. on 7.
Valuation
Profitability
| Metric | CNSY | GTBP | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 41.67% | 65.16% |
| Operating margin | (628.12%) | 0.00% | 0.00% |
| Net margin | (526.48%) | 0.00% | 0.00% |
| Free cash flow margin | (560.29%) | 0.00% | 0.00% |
| Return on equity | (520.84%) | 102.03% | (56.36%) |
| Return on assets | (181.53%) | (176.27%) | (48.04%) |
| Return on invested capital | (532.77%) | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack